BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37014028)

  • 21. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
    Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
    Anantram A; Kundaikar H; Degani M; Prabhu A
    J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro biological and in silico molecular docking and ADME studies of a substituted triazine-coordinated cadmium(II) ion: efficient cytotoxicity, apoptosis, genotoxicity, and nuclease-like activity plus binding affinity towards apoptosis-related proteins.
    Anjomshoa M; Sahihi M; Fatemi SJ; Shayegan S; Farsinejad A; Amirheidari B
    Biometals; 2022 Jun; 35(3):549-572. PubMed ID: 35366135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiproliferative and apoptosis-induction studies of 5-hydroxy 3',4',7-trimethoxyflavone in human breast cancer cells MCF-7: an in vitro and in silico approach.
    Sudha A; Srinivasan P; Kanimozhi V; Palanivel K; Kadalmani B
    J Recept Signal Transduct Res; 2018 Jun; 38(3):179-190. PubMed ID: 29734849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
    Hajipour F; Mahdavinia M; Fereidoonnezhad M
    Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity,
    Tantawy MA; Shaheen S; Kattan SW; Alelwani W; Barnawi IO; Elmgeed GA; Nafie MS
    J Biomol Struct Dyn; 2022 Jul; 40(10):4352-4365. PubMed ID: 33300466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural product-inspired rational design, synthesis and biological evaluation of 2,3-dihydropyrano[2,3-f]chromen-4(8H)-one based hybrids as potential mitochondrial apoptosis inducers.
    Sakthivel P; Ilangovan A; Kaushik MP
    Eur J Med Chem; 2016 Oct; 122():302-318. PubMed ID: 27376493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular docking and molecular dynamic simulations of apoptosis proteins with potential anticancer compounds present in
    Ismail NZ; Mohamed WAS; Ab Rahim N; Hashim NM; Adebayo IA; Mohamad Zain NN; Arsad H
    J Biomol Struct Dyn; 2023; 41(13):6104-6120. PubMed ID: 35899385
    [No Abstract]   [Full Text] [Related]  

  • 29. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
    Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
    Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor β-activated kinase 1 activation.
    Li M; Qi Y; Wei J; Lu L; Zhao X; Zhou L
    Tumour Biol; 2017 Mar; 39(3):1010428317695966. PubMed ID: 28345459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli.
    Dwivedi GR; Upadhyay HC; Yadav DK; Singh V; Srivastava SK; Khan F; Darmwal NS; Darokar MP
    Chem Biol Drug Des; 2014 Apr; 83(4):482-92. PubMed ID: 24267788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Studies on Novel Antitumor Bis 1,4-Dihydropyridine Derivatives Against Lung Carcinoma and their Limited Side Effects on Normal Melanocytes.
    Mohamed MF; Ibrahim NS; Elwahy AHM; Abdelhamid IA
    Anticancer Agents Med Chem; 2018; 18(15):2156-2168. PubMed ID: 30338746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells.
    Nafie MS; Amer AM; Mohamed AK; Tantawy ES
    Bioorg Med Chem; 2020 Dec; 28(24):115828. PubMed ID: 33166925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
    Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a promising hit from a new series of pyrazolo[1,5-a]pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro-apoptotic properties through a multistep in vitro assessment.
    Elgiushy HR; Mohamed SH; Taha H; Sawaf H; Hassan Z; Abou-Taleb NA; El-Labbad EM; Hassan AS; Abouzid KAM; Hammad SF
    Bioorg Chem; 2022 Mar; 120():105646. PubMed ID: 35134645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
    Kadhim ZY; Alqaraghuli HGJ; Abd MT
    Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
    Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
    Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.